Stoke Therapeutics Announces Presentations of STK-002, an Investigational Medicine for the Treatment of Autosomal Dominant Optic Atrophy (ADOA), at the American Academy of Ophthalmology (AAO) 2026 Ann
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
| (NASDAQ: STOK) | Delayed: 25.68 -0.93 (3.49%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $26.61 | 52 Week High | $ | |||
| Open | $26.83 | 52 Week Low | $ | |||
| Day High | $27.22 | P/E | N/A | |||
| Day Low | $25.31 | EPS | $ | |||
| Volume | 2,257,815 | |||||
